Company Overview - Autonomix Medical, Inc. is a medical device company focused on innovative technologies for diagnosing and treating diseases of the nervous system [4] - The company's first-in-class platform technology includes a catheter-based microchip sensing array that detects neural signals with approximately 3,000 times greater sensitivity than current technologies [4] - The technology aims to enable transvascular diagnosis and treatment of peripheral nervous system diseases [4] Technology Development - Initial development of the technology is targeted at pain treatment, specifically for pancreatic cancer, which causes severe pain and lacks reliable treatment options [5] - The technology has the potential to address various indications, including cardiology, hypertension, and chronic pain management [5] - The technology is currently investigational and has not yet received marketing clearance in the United States [5] Industry Engagement - Autonomix's abstract has been accepted for poster presentation at the 2025 Society of Interventional Radiology Annual Scientific Meeting, scheduled for March 29-April 2, 2025 [1][2] - The Society of Interventional Radiology represents over 8,000 professionals dedicated to improving patient care through image-guided therapies [2] - The annual meeting will focus on emerging methodologies, groundbreaking research, and networking opportunities within the interventional radiology field [2][3] Presentation Details - The presentation titled "Pain Mitigation in Pancreatic Adenocarcinoma: An Interim Analysis of Neurolysis via Transvascular RF Energy-Based Ablation" will be delivered by Dr. Bela Kis on March 31, 2025, from 12:10 PM to 1:10 PM CT [9]
Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting